CrossrefInfokarte
Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review)
Oncology Reports · 2024-12-13 · 53 (2)
DOI: 10.3892/or.2024.8854 ↗Abstract
Kein Abstract verfügbar.
EUVIMED